Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-27

Clinical Trial Update: Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating depleted donor stem cell transplantation in children and adults with Fanconi anemia using a conditioning regimen that i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Briquilimab

Snippet

Sponsor: Porteus, Matthew, MD | Conditions: Fanconi Anemia | Phase 1, Phase 2 | Status: RECRUITING